日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effect of Tofogliflozin on Urinary Albumin-to-Creatinine Ratio vs. Metformin in Diabetic Kidney Disease: Rationale and Study Protocol of the TRUTH-DKD Trial

托格列净与二甲双胍对糖尿病肾病患者尿白蛋白/肌酐比值的影响:TRUTH-DKD试验的理论基础和研究方案

Kimura, Kazuhiro; Takagi, Yoshiko; Harada, Makoto; Ueda, Shinichiro; Minamisawa, Masatoshi; Sonoda, Kosuke; Oiwa, Ako; Yazaki, Yoshikazu; Sakurai, Shunpei; Tomita, Takeshi; Kaneko, Kazuaki; Yamamoto, Kazuya; Takama, Noriaki; Momose, Shigeki; Inobe, Yoshito; Nogi, Kazutaka; Koshikawa, Megumi; Misawa, Takuo; Kasai, Toshio; Tsutsui, Hiroshi; Watanabe, Noboru; Yamazaki, Kyohei; Miyamoto, Takahide; Midorikawa, Takashi; Usui, Tatsuya; Saigusa, Tatsuya; Motoki, Hirohiko; Saito, Yoshihiko; Kamijo, Yuji; Komatsu, Mitsuhisa; Kuwahara, Koichiro

Exploratory study on the relationship between urinary sodium/potassium ratio, salt intake, and the antihypertensive effect of esaxerenone: the ENaK Study

探索尿钠/钾比值、盐摄入量与依沙克雷酮降压作用之间关系的研究:ENaK 研究

Katsuya, Tomohiro; Inobe, Yoshito; Uchiyama, Kazuaki; Nishikawa, Tetsuo; Hirano, Kunio; Kato, Mitsutoshi; Fukui, Toshiki; Hatta, Tsuguru; Iwasaki, Arata; Ishii, Hajime; Sugiura, Toshiyuki; Taguchi, Takashi; Tanabe, Ayumi; Sugimoto, Kotaro; Shimosawa, Tatsuo

Efficacy and Safety of Esaxerenone in Hypertensive Patients with Diabetes Mellitus Undergoing Treatment with Sodium-Glucose Cotransporter 2 Inhibitors (EAGLE-DH)

依沙克雷酮治疗接受钠-葡萄糖协同转运蛋白2抑制剂治疗的高血压合并糖尿病患者的疗效和安全性(EAGLE-DH)

Motoki, Hirohiko; Inobe, Yoshito; Fukui, Toshiki; Iwasaki, Arata; Hiramitsu, Shinya; Koyama, Sekiya; Masuda, Izuru; Sekimura, Noriyuki; Yamamoto, Kazuya; Sato, Ai; Komatsu, Mitsuhisa; Taguchi, Takashi; Shiosakai, Kazuhito; Sugimoto, Kotaro; Kuwahara, Koichiro

CD28 confers CD4+ T cells with resistance to cyclosporin A and tacrolimus but to different degrees

CD28 使 CD4+ T 细胞对环孢素 A 和他克莫司产生耐药性,但程度不同

Hiroyuki Kawai, Fumiko Yagyu, Aki Terada, Tsukasa Matsunaga, Manabu Inobe

N-Acyldopamine induces aggresome formation without proteasome inhibition and enhances protein aggregation via p62/SQSTM1 expression

N-酰多巴胺在不抑制蛋白酶体的情况下诱导聚集体形成,并通过 p62/SQSTM1 表达增强蛋白质聚集

Gen Matsumoto, Tomonao Inobe, Takanori Amano, Kiyohito Murai, Nobuyuki Nukina, Nozomu Mori

Conserved Sequence Preferences Contribute to Substrate Recognition by the Proteasome.

保守序列偏好有助于蛋白酶体识别底物

Yu Houqing, Singh Gautam Amit K, Wilmington Shameika R, Wylie Dennis, Martinez-Fonts Kirby, Kago Grace, Warburton Marie, Chavali Sreenivas, Inobe Tomonao, Finkelstein Ilya J, Babu M Madan, Matouschek Andreas

Novel method for the high-throughput production of phosphorylation site-specific monoclonal antibodies

高通量生产磷酸化位点特异性单克隆抗体的新方法

Nobuyuki Kurosawa, Yuka Wakata, Tomonao Inobe, Haruki Kitamura, Megumi Yoshioka, Shun Matsuzawa, Yoshihiro Kishi, Masaharu Isobe

Sequence composition of disordered regions fine-tunes protein half-life.

无序区域的序列组成可以微调蛋白质的半衰期

Fishbain Susan, Inobe Tomonao, Israeli Eitan, Chavali Sreenivas, Yu Houqing, Kago Grace, Babu M Madan, Matouschek Andreas

Regulation of Proteasomal Degradation by Modulating Proteasomal Initiation Regions

通过调控蛋白酶体起始区来调控蛋白酶体降解

Takahashi, Kazunobu; Matouschek, Andreas; Inobe, Tomonao

N-Terminal Coiled-Coil Structure of ATPase Subunits of 26S Proteasome Is Crucial for Proteasome Function.

26S蛋白酶体ATPase亚基的N端螺旋卷曲结构对蛋白酶体功能至关重要

Inobe Tomonao, Genmei Reiko